<?xml version="1.0" encoding="UTF-8"?>
<p>From the identification of cases through surveillance to randomized trials of new preventive and therapeutic interventions, much of the success reported over the last 25 years has benefited from, if not been a direct result of, robust use of the epidemiologic approach. The epidemiologic approach of analyzing the causes and distributions of diseases in populations to identify and implement new ways to prevent and control disease will continue to inform HIV science in the future.</p>
